ClinResearch, ADDPLAN, and Fulcrum Pharma Combine for Biopharm Services
A group of investors including The Halifax Group and SV Life Sciences announced a series of acquisitions that are an integral part of its strategy to build a global differentiated biopharmaceutical services company.
Led by Patrick K. Donnelly, one of the investors and former CEO of PRA International, the investment group purchased all shares of ClinResearch and ADDPLAN, global leaders in adaptive trial services and software, and Fulcrum Pharma, a UK-based company that provides comprehensive drug development, regulatory and safety services.
“With these announcements, and our previous partnership with Trio Clinical Research, we can now offer clients around the world access to innovative, comprehensive and proven development capabilities,” Mr. Donnelly said. “With the constant pressures and challenges currently facing the drug industry, we need to approach drug and device development from a different and more dynamic paradigm.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
